Aggregate-derived cohort evidence
Supercentenarian single-cell aging clock
Study-level participant index for the Longevity Cohort module. Open a tracking ID to inspect its de-identified group metadata, source scope, and data-access notes.
Tracking rows summarize published group counts; they do not identify individual donors.
Dataset switcher
Choose a curated cohort record
Cohort
Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation
Technology
scRNA-seq + single-cell aging clock + ribosome-inhibition assay
Data access
GSE213516 open; SC not local
GEO GSE213516 open (10/17 Shanghai reference processed); supercentenarian hum0229 not local
GEO GSE213516 open (10/17 Shanghai reference processed); supercentenarian hum0229 not local
Aggregate-derived tracking
Exact participant-level age, sex and sample accession are not mapped in the currently curated public metadata. These LACA tracking IDs are derived from published aggregate group counts. They are not original
participant, donor, or biosample identifiers.
Open GEO analysis
GSE213516 processed samples
Local scanpy analysis of the public GEO processed matrices (10 of 17 Shanghai reference samples; 83,191 cells). Supercentenarian samples (hum0229) are not on this host. The aging score is a heuristic proxy, not the published clock.
10GEO samples on disk
83,191Cells in local object
10 / 17Shanghai reference coverage
hum0229Supercentenarian data not local
| GEO sample | GSM | Sex / age code | Cells | Mean aging | Flag | B% | NK% | Mono% | CD8T% | Detail |
|---|---|---|---|---|---|---|---|---|---|---|
| F55 | GSM6588517 | Female / 55 | 8,948 | 0.903 | high | 6.4 | 0.0 | 2.1 | 0.0 | View sample |
| F65 | GSM6588520 | Female / 65 | 7,715 | 0.250 | medium | 2.6 | 0.4 | 4.5 | 0.0 | View sample |
| F60 | GSM6588518 | Female / 60 | 8,263 | 0.220 | medium | 4.2 | 0.2 | 2.9 | 0.0 | View sample |
| F47 | GSM6588513 | Female / 47 | 7,831 | 0.168 | medium | 1.6 | 31.1 | 47.7 | 0.1 | View sample |
| F66 | GSM6588515 | Female / 66 | 7,845 | -0.074 | medium | 7.2 | 44.3 | 21.2 | 0.1 | View sample |
| F40 | GSM6588519 | Female / 40 | 6,041 | -0.106 | medium | 5.0 | 0.0 | 1.5 | 0.3 | View sample |
| F36 | GSM6588512 | Female / 36 | 10,641 | -0.143 | medium | 7.1 | 29.0 | 24.7 | 0.1 | View sample |
| F58 | GSM6588514 | Female / 58 | 9,944 | -0.177 | medium | 4.3 | 1.5 | 17.8 | 14.6 | View sample |
| F77 | GSM6588516 | Female / 77 | 7,581 | -0.442 | low | 3.1 | 9.9 | 21.2 | 0.3 | View sample |
| F30 | GSM6588511 | Female / 30 | 8,382 | -0.631 | low | 7.9 | 5.9 | 10.4 | 5.1 | View sample |
Cohort evidence index
Tracking Table
24 aggregate-derived tracking rows in this study; 50 rows per page.
CEN 7OFF 17CTRL 0Aggregate-derived · no identity encoded
Swipe horizontally to inspect all tracking fields →
| Details | ||||||
|---|---|---|---|---|---|---|
|
LC-37379396-SC-001
LACA tracking ID
|
Supercentenarian | Study-defined supercentenarian group; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-SC-002
LACA tracking ID
|
Supercentenarian | Study-defined supercentenarian group; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-SC-003
LACA tracking ID
|
Supercentenarian | Study-defined supercentenarian group; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-SC-004
LACA tracking ID
|
Supercentenarian | Study-defined supercentenarian group; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-SC-005
LACA tracking ID
|
Supercentenarian | Study-defined supercentenarian group; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-SC-006
LACA tracking ID
|
Supercentenarian | Study-defined supercentenarian group; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-SC-007
LACA tracking ID
|
Supercentenarian | Study-defined supercentenarian group; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-001
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-002
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-003
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-004
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-005
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-006
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-007
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-008
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-009
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-010
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-011
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-012
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-013
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-014
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-015
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-016
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
|
LC-37379396-CTL-017
LACA tracking ID
|
Control / reference | Published reference-group range: 28–77 years; individual age unavailable | Not reported at participant level | Seven supercentenarians + Shanghai reference cohort; Wuhan/Japan validation | Peripheral blood mononuclear cells (PBMC) | View Detail |
Showing tracking rows